FDA Approves New Drug to Treat Chronic Inflammatory Diseases

May 21, 2014 3:13 PM

15 0

Inflammatory diseases such as ulcerative colitis and Crohn's disease have no cure and some who suffer from them don't respond to existing treatments. The FDA approved a new drug on Tuesday to help over a million Americans with such diseases.

The new drug, vedolizumab, which will be sold under the brand name Entyvio, is a product of Takeda Pharmaceutical of Japan. The Food and Drug Administration made the announcement of its approval on Tuesday and hopes that it will help those who do not benefit from standard treatments for ulcerative c...

Also read: FDA approves BioMarin rare metabolic disorder drug, shares rise

Read more

To category page